Follow-up at 1 year and beyond of women with gestational diabetes treated with insulin and/or oral glucose-lowering agents: a core outcome set using a Delphi survey

Published on Nov 1, 2019in Diabetologia7.113
· DOI :10.1007/s00125-019-4935-9
Delia Bogdanet1
Estimated H-index: 1
(NUI: National University of Ireland),
Catriona Reddin (NUI: National University of Ireland)+ 20 AuthorsFidelma Dunne35
Estimated H-index: 35
(NUI: National University of Ireland)
Aims/hypothesis Gestational diabetes mellitus (GDM) is linked with a higher lifetime risk for the development of impaired fasting glucose, impaired glucose tolerance, type 2 diabetes, the metabolic syndrome, cardiovascular disease, postpartum depression and tumours. Despite this, there is no consistency in the long-term follow-up of women with a previous diagnosis of GDM. Further, the outcomes selected and reported in the research involving this population are heterogeneous and lack standardisation. This amplifies the risk of reporting bias and diminishes the likelihood of significant comparisons between studies. The aim of this study is to develop a core outcome set (COS) for RCTs and other studies evaluating the long-term follow-up at 1 year and beyond of women with previous GDM treated with insulin and/oral glucose-lowering agents.
  • References (23)
  • Citations (0)
📖 Papers frequently viewed together
13 Citations
11 Citations
9 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Caroline K. Kramer (MSH: Mount Sinai Hospital, Toronto)H-Index: 2
#2Sara Campbell (MSH: Mount Sinai Hospital, Toronto)H-Index: 1
Last. Ravi Retnakaran (MSH: Mount Sinai Hospital, Toronto)H-Index: 36
view all 3 authors...
Aims/hypothesis Women who develop gestational diabetes mellitus (GDM) have an elevated lifetime risk of type 2 diabetes mellitus. Recently, a series of studies has suggested that women with GDM also have an increased risk of cardiovascular disease (CVD). However, it is unclear if this risk is dependent upon the intercurrent development of type 2 diabetes. Thus, we conducted a systematic review and meta-analysis to evaluate the impact of GDM on future risk of incident CVD and to ascertain the rol...
13 CitationsSource
#1Delia Bogdanet (National University of Ireland, Galway)H-Index: 1
#2Aoife M. Egan (National University of Ireland, Galway)H-Index: 11
Last. Fidelma Dunne (National University of Ireland, Galway)H-Index: 35
view all 9 authors...
Background Gestational diabetes (GDM) is associated with an increased lifetime risk for the development of glucose abnormalities, metabolic syndrome, cardiovascular disease, depression and tumours. Despite this high risk of additional comorbidities, there is no standardised approach to the long-term follow-up of women with a previous diagnosis of GDM. Also, there is no standardisation of outcome selection and reporting in studies involving this population. This increases the risk of reporting bi...
1 CitationsSource
#1Elizabeth Gargon (University of Liverpool)H-Index: 15
#2Paula R. Williamson (University of Liverpool)H-Index: 64
Last. Mike Clarke ('QUB': Queen's University Belfast)H-Index: 99
view all 6 authors...
This letter describes the substantial activity on the Core Outcome Measure in Effectiveness Trials (COMET) website in 2015, updating our earlier progress reports for the period from the launch of the COMET website and database in August 2011 to December 2014. As in previous years, 2015 saw further increases in the annual number of visits to the website, the number of pages viewed and the number of searches undertaken. The sustained growth in use of the website and database suggests that COMET is...
15 CitationsSource
#1Paige D. Wartko (UW: University of Washington)H-Index: 3
#2Tiffany L. Beck (UW: University of Washington)H-Index: 4
Last. Stephen E. Hawes (UW: University of Washington)H-Index: 44
view all 5 authors...
Purpose Excess circulating insulin may contribute to endometrial cancer (EC) development; studies suggest increased risk of EC associated with type 2 diabetes. We investigated whether gestational diabetes is associated with increased risk of EC and its precursor, endometrial hyperplasia (EH).
7 CitationsSource
31 CitationsSource
#1Diane Farrar (Bradford Royal Infirmary)H-Index: 16
#2Mark Simmonds (Ebor: University of York)H-Index: 21
Last. Debbie A. Lawlor (UoB: University of Bristol)H-Index: 118
view all 7 authors...
Objective To investigate the effectiveness of different treatments for gestational diabetes mellitus (GDM). Design Systematic review, meta-analysis and network meta-analysis. Methods Data sources were searched up to July 2016 and included MEDLINE and Embase. Randomised trials comparing treatments for GDM (packages of care (dietary and lifestyle interventions with pharmacological treatments as required), insulin, metformin, glibenclamide (glyburide)) were selected by two authors and double checke...
17 CitationsSource
#1Heidi HakkarainenH-Index: 5
#2Hanna HuopioH-Index: 12
Last. Seppo Heinonen (HYKS: Helsinki University Central Hospital)H-Index: 33
view all 6 authors...
AbstractThe aim of this study was to evaluate the incidence of metabolic syndrome (MetS) during long-term follow-up of women with gestational diabetes (GDM). Furthermore, we evaluated the glycemic measures from an oral glucose tolerance test (OGTT) during pregnancy as predictors of incident MetS. Women diagnosed with GDM were divided into two groups according to the results of OGTT: one abnormal value = GDM1 (n = 338) and two abnormal values = GDM2 (n = 151), while women with normal glucose tole...
12 CitationsSource
#1Jamie J Kirkham (University of Liverpool)H-Index: 29
#2Sarah L. Gorst (University of Liverpool)H-Index: 9
Last. Paula R. Williamson (University of Liverpool)H-Index: 64
view all 12 authors...
Background Core outcome sets (COS) can enhance the relevance of research by ensuring that outcomes of importance to health service users and other people making choices about health care in a particular topic area are measured routinely. Over 200 COS to date have been developed, but the clarity of these reports is suboptimal. COS studies will not achieve their goal if reports of COS are not complete and transparent. Methods and Findings In recognition of these issues, an international group that...
105 CitationsSource
#1Elizabeth Gargon (University of Liverpool)H-Index: 15
#2Paula R. Williamson (University of Liverpool)H-Index: 64
Last. Mike Clarke ('QUB': Queen's University Belfast)H-Index: 99
view all 5 authors...
The COMET Initiative database is a repository of studies relevant to the development of core outcome sets (COS). Use of the website continues to increase, with more than 16,500 visits in 2014 (36 % increase over 2013), 12,257 unique visitors (47 % increase), 9780 new visitors (43 % increase) and a rise in the proportion of visits from outside the UK (8565 visits; 51 % of all visits). By December 2014, a total of 6588 searches had been completed, with 2383 in 2014 alone (11 % increase). The growi...
29 CitationsSource
#1Valerie Smith (Trinity College, Dublin)H-Index: 17
#2Mike Clarke ('QUB': Queen's University Belfast)H-Index: 99
Last. Elizabeth Gargon (University of Liverpool)H-Index: 15
view all 4 authors...
Abstract Objectives To survey the outcomes used in Cochrane Reviews, as part of our work within the Core Outcome Measures in Effectiveness Trials Initiative. Study Design and Setting A descriptive survey of Cochrane Reviews, divided by Cochrane Review Group (CRG), published in full for the first time in 2007 and 2011. Outcomes specified in the methods section of each review and outcomes reported in the results section of each review were of interest, in this exploration of the common use of outc...
27 CitationsSource
Cited By0
#1Aoife M. Egan (Mayo Clinic)H-Index: 11
#3Delia Bogdanet (National University of Ireland, Galway)H-Index: 1
Last. Cheril Clarson (UWO: University of Western Ontario)H-Index: 15
view all 23 authors...
The aim of this systematic review was to develop core outcome sets (COSs) for trials evaluating interventions for the prevention or treatment of gestational diabetes mellitus (GDM). We identified previously reported outcomes through a systematic review of the literature. These outcomes were presented to key stakeholders (including patient representatives, researchers and clinicians) for prioritisation using a three-round, e-Delphi study. A priori consensus criteria informed which outcomes were b...
#1Karoline Kragelund Nielsen (Steno Diabetes Center)
Last. Line Hillersdal (UCPH: University of Copenhagen)H-Index: 2
view all 13 authors...
BACKGROUND: Gestational diabetes mellitus (GDM) is associated with an increased risk of future diabetes in both mother, father and offspring. More knowledge is needed about how to effectively reduce the risk of diabetes through sustained behavioural interventions in these families. The Face-it intervention is a complex health promotion intervention embedded in multi-level supportive environments. The aim of the intervention is to reduce type 2 diabetes risk and increase quality of life among fam...